Stemline Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Stemline Therapeutics

Access the complete profile.

Stemline Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	750 Lexington Ave Fl 4 New York, NY 10022

Stemline Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Stemline Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Stemline Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Stemline Therapeutics is a publicly traded company on NCM using the ticker symbol STML. Detailed information on company financials and operating reports can be found here: NCM: STML

Stemline Therapeutics Annual Revenue and Growth Rate

Stemline Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Stemline Therapeutics's revenues are gauged from an analysis of company filings.

Investor Activity

Stemline Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 17, 2012	16	N/A	$0 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Stemline Therapeutics is developing and marketing. Stemline Therapeutics doesn't have any recent trademark applications, indicating Stemline Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
STEMLINE ARC providing health information; providing medical information	07/28/2018
RAPCELDA pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agents in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseases	04/02/2018
ELZONRIS pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases	03/21/2018

See all trademarks and details in the Full Report.

Market Share of Stemline Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Stemline Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Stemline Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ITI	New York, NY	100
STEMLINE THERAPEUTICS	New York, NY	67
TG THERAPEUTICS	New York, NY	58
POPULATION COUNCIL	New York, NY	53
NEW YORK GENOME CENTER	New York, NY	33
OXFORD NANOPORE TECHNOLOGIES	New York, NY	23

Future Competition: Stemline Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Stemline Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)